It's one of the things that I like about this drug, and the Acne formulation as well for that matter which I maintain is the real revenue giant if approved, is they don't cure the problem. They only treat the symptoms. So if this formulation works as intended for x% of the population then logic dictates most should return and the patient base will consistently grow as new prospective patients are born and are afflicted with the condition - Long term view.
Acne is the one I am most exited for - the target population is massive and it hit's the cosmetic / vanity sweet spot that redefines the drug into a must have for basically anyone going through puberty and it's a self generating patient pool as everyone goes through puberty and a high % of people suffer acne during that time.
Probably a rather callous point of view from the patients perspective but from a Revenue perspective ...........
- Forums
- ASX - By Stock
- BOT - Anything but charting
It's one of the things that I like about this drug, and the Acne...
-
- There are more pages in this discussion • 2,575 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
(20min delay)
|
|||||
Last
37.5¢ |
Change
0.005(1.35%) |
Mkt cap ! $675.7M |
Open | High | Low | Value | Volume |
37.0¢ | 37.5¢ | 36.8¢ | $768.6K | 2.076M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
8 | 73796 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
37.5¢ | 100095 | 11 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
8 | 73795 | 0.370 |
20 | 613562 | 0.365 |
20 | 411970 | 0.360 |
17 | 381834 | 0.355 |
37 | 1412801 | 0.350 |
Price($) | Vol. | No. |
---|---|---|
0.375 | 101738 | 11 |
0.380 | 311855 | 10 |
0.385 | 185400 | 3 |
0.390 | 100550 | 3 |
0.395 | 151300 | 3 |
Last trade - 15.21pm 08/10/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |